Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -4.057% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CCN1CCN(c2ccc(NC(=O)c3ccco3)cc2Cl)CC1
(b) CCCn1c(N)c(C(=O)CSc2nnc3n2CCCCC3)c(=O)[nH]c1=O
(c) Cl.O=C(c1ccc(F)cc1)C(CCCCCC(CN1CCOCC1)C(=O)c1ccc(F)cc1)CN1CCOCC1
Answer: a. CCN1CCN(c2ccc(NC(=O)c3ccco3)cc2Cl)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(c2ccc(NC(=O)c3ccco3)cc2Cl)CC1
CCN1CCN(c2ccc(NC(=O)c3ccco3)cc2Cl)CC1
N-[3-chloro-4-(4-ethyl-1,4-diazinan-1-yl)phenyl]furan-2-carboxamide